Triamterene (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Triamterene" in English language version.

refsWebsite

Global rank English rank

7nih.gov

4^th place

6doi.org

2^nd place

4nytimes.com

7^th place

3web.archive.org

1^st place

3fda.gov

447^th place

338^th place

2semanticscholar.org

11^th place

8^th place

2philly.com

664^th place

398^th place

2pharmamedtechbi.com

low place

1losalt.com

low place

1books.google.com

3^rd place

1latimes.com

22^nd place

19^th place

1joc.com

low place

8,062^nd place

1drugs.com

399^th place

333^rd place

1aafp.org

1,916^th place

1,419^th place

aafp.org

Swartz R, Longwell P (March 2005). "Treatment of vertigo" (PDF). American Family Physician. 71 (6): 1115–1122. PMID 15791890.

books.google.com

Seaman J, Landry JT (2011). Mylan 50 Years of Unconventional Success. University Press of New England. p. 50. ISBN 9781611682700.

doi.org

Favre L, Glasson P, Vallotton MB (March 1982). "Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects". Annals of Internal Medicine. 96 (3): 317–320. doi:10.7326/0003-4819-96-3-317. PMID 6949485.
Busch AE, Suessbrich H, Kunzelmann K, Hipper A, Greger R, Waldegger S, et al. (September 1996). "Blockade of epithelial Na+ channels by triamterenes - underlying mechanisms and molecular basis". Pflügers Archiv. 432 (5): 760–766. doi:10.1007/s004240050196. PMID 8772124. S2CID 10489391.
Crosley AP, Ronquillo LM, Strickland WH, Alexander F (February 1962). "Triamterene, a new natruretic agent. Preliminary observations in man". Annals of Internal Medicine. 56 (2): 241–251. doi:10.7326/0003-4819-56-2-241. PMID 13882367.
Heath WC, Freis ED (October 1963). "Triamterene with Hydrochlorothiazide in the Treatment of Hypertension". JAMA. 186 (2): 119–122. doi:10.1001/jama.1963.03710020039012. PMID 14056525.
Boehm G, Yao L, Han L, Zheng Q (September 2013). "Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984". Acta Pharmaceutica Sinica B. 3 (5): 297–311. doi:10.1016/j.apsb.2013.07.004.
Sloane PD, Coeytaux RR, Beck RS, Dallara J (May 2001). "Dizziness: state of the science". Annals of Internal Medicine. 134 (9 Pt 2): 823–832. doi:10.7326/0003-4819-134-9_Part_2-200105011-00005. PMID 11346317. S2CID 6762911.

drugs.com

"Generic Maxzide". Drugs.com. Retrieved 8 September 2016.

fda.gov

accessdata.fda.gov

FDA "Approval History NDA 016042: Dyazide". U.S. Food and Drug Administration. Retrieved 8 September 2016.
"Approval History NDA 019129: Maxzide". U.S. Food and Drug Administration. Retrieved 8 September 2016.

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.

joc.com

Reid K (November 17, 1987). "US Judge to Rule on Drug Marketing". Journal of Commerce.

latimes.com

Cimons M (29 August 1989). "FDA to Lift OK of Last Dyazide Generic Version". Los Angeles Times.

losalt.com

"Advisory Statement" (PDF). LoSalt. Archived from the original (PDF) on 10 December 2005.

nih.gov

pubmed.ncbi.nlm.nih.gov

Favre L, Glasson P, Vallotton MB (March 1982). "Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects". Annals of Internal Medicine. 96 (3): 317–320. doi:10.7326/0003-4819-96-3-317. PMID 6949485.
Busch AE, Suessbrich H, Kunzelmann K, Hipper A, Greger R, Waldegger S, et al. (September 1996). "Blockade of epithelial Na+ channels by triamterenes - underlying mechanisms and molecular basis". Pflügers Archiv. 432 (5): 760–766. doi:10.1007/s004240050196. PMID 8772124. S2CID 10489391.
Crosley AP, Ronquillo LM, Strickland WH, Alexander F (February 1962). "Triamterene, a new natruretic agent. Preliminary observations in man". Annals of Internal Medicine. 56 (2): 241–251. doi:10.7326/0003-4819-56-2-241. PMID 13882367.
Heath WC, Freis ED (October 1963). "Triamterene with Hydrochlorothiazide in the Treatment of Hypertension". JAMA. 186 (2): 119–122. doi:10.1001/jama.1963.03710020039012. PMID 14056525.
Swartz R, Longwell P (March 2005). "Treatment of vertigo" (PDF). American Family Physician. 71 (6): 1115–1122. PMID 15791890.
Sloane PD, Coeytaux RR, Beck RS, Dallara J (May 2001). "Dizziness: state of the science". Annals of Internal Medicine. 134 (9 Pt 2): 823–832. doi:10.7326/0003-4819-134-9_Part_2-200105011-00005. PMID 11346317. S2CID 6762911.

nlm.nih.gov

"Triamterene and Hydrochlorothiazide". MedlinePlus. U.S. National Library of Medicine. National Institutes of Health. 1 September 2008.

nytimes.com

Strickland C (15 October 1989). "Bolar: A Drug Company Under Siege". The New York Times.
Freudenheim M (28 February 1991). "Bolar Plans Guilty Plea On Generics". The New York Times.
Freudenheim M (10 September 1989). "Exposing the F.D.A." The New York Times.
Andrews EL (31 July 1989). "F.D.A. Inquiry on Generic Drugs Focuses on Changes in Ingredients". The New York Times.

pharmamedtechbi.com

pink.pharmamedtechbi.com

"Bolar Recalls Generic Version Of Dyazide And Extended Release Phenytoin, Saying "Bioequivalence Cannot Be Assured"; Products; Represent 52% of Sales". Pink Sheet. February 5, 1990.
"Mylan's Maxzide is "Approvable" at FDA: Lederle To Market Brand Competition to Smithkline's No. 3-Ranked Dyazide; Final Approval Anticipated "Imminently"". Pink Sheet. 22 October 1984.

philly.com

articles.philly.com

Wolf R (22 August 1987). Smithkline Loses Exclusive Rights To Drug. Archived from the original on September 26, 2015. {{cite book}}: |work= ignored (help)
Shaw D (February 27, 1991). "U.S. Charges Bolar Pharmaceutical With Misrepresenting Its Products". The Philadelphia Inquirer. Archived from the original on September 16, 2016.

semanticscholar.org

api.semanticscholar.org

Busch AE, Suessbrich H, Kunzelmann K, Hipper A, Greger R, Waldegger S, et al. (September 1996). "Blockade of epithelial Na+ channels by triamterenes - underlying mechanisms and molecular basis". Pflügers Archiv. 432 (5): 760–766. doi:10.1007/s004240050196. PMID 8772124. S2CID 10489391.
Sloane PD, Coeytaux RR, Beck RS, Dallara J (May 2001). "Dizziness: state of the science". Annals of Internal Medicine. 134 (9 Pt 2): 823–832. doi:10.7326/0003-4819-134-9_Part_2-200105011-00005. PMID 11346317. S2CID 6762911.

web.archive.org

"Advisory Statement" (PDF). LoSalt. Archived from the original (PDF) on 10 December 2005.
Wolf R (22 August 1987). Smithkline Loses Exclusive Rights To Drug. Archived from the original on September 26, 2015. {{cite book}}: |work= ignored (help)
Shaw D (February 27, 1991). "U.S. Charges Bolar Pharmaceutical With Misrepresenting Its Products". The Philadelphia Inquirer. Archived from the original on September 16, 2016.